CellaVision AB (C26) Financial Statements
CellaVision AB Financial Overview
CellaVision AB's market cap is currently $423.70M. The company's EPS TTM is $5.78; its P/E ratio is 33.84; and it has a dividend yield of 1.50%. CellaVision AB is estimated to report earnings on February 4, 2027, and the estimated EPS forecast is $0.19. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 758.97M | $ 723.22M | $ 677.29M | $ 639.34M | $ 565.55M |
| Gross Profit | $ 519.88M | $ 487.07M | $ 463.04M | $ 438.32M | $ 392.30M |
| Operating Income | $ 202.07M | $ 177.68M | $ 167.05M | $ 158.27M | $ 162.73M |
| EBITDA | $ 237.28M | $ 226.02M | $ 207.25M | $ 190.87M | $ 193.60M |
| Net Income | $ 153.08M | $ 140.72M | $ 130.31M | $ 118.33M | $ 125.34M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 188.22M | $ 149.43M | $ 121.64M | $ 108.05M | $ 130.29M |
| Total Assets | $ 1.09B | $ 1.01B | $ 928.71M | $ 891.75M | $ 825.21M |
| Total Debt | $ 25.65M | $ 26.85M | $ 64.70M | $ 102.50M | $ 136.65M |
| Net Debt | $ -162.56M | $ -122.58M | $ -56.94M | $ -5.56M | $ 6.37M |
| Total Liabilities | $ 207.31M | $ 196.16M | $ 212.32M | $ 250.12M | $ 281.93M |
| Stockholders' Equity | $ 887.58M | $ 815.73M | $ 716.39M | $ 641.63M | $ 543.28M |
| Cash Flow | |||||
| Free Cash Flow | $ 181.72M | $ 186.44M | $ 109.96M | $ 67.85M | $ 75.41M |
| Operating Cash Flow | $ 200.53M | $ 198.44M | $ 196.44M | $ 137.28M | $ 159.72M |
| Investing Cash Flow | $ -86.16M | $ -76.01M | $ -85.53M | $ -70.01M | $ -84.34M |
| Financing Cash Flow | $ -74.59M | $ -95.09M | $ -97.04M | $ -90.41M | $ -48.48M |
Currency in SEK